of cases was 38784, including 568 active cases and 37779 recoveries and 437 deaths. as of 21 february, the total number of cases was 39030, including 119 active cases and 38470 recoveries and 441 fatalities. as of 25 february, the total number of cases was 39060, including 78 active cases and 38540 recoveries and 442 fatalities. as of 19 march, the total number of cases was 39113, including 13 active cases and 38651 recoveries and 449 deaths. apr to jun 2022 as of 11 april, the total number of cases in sikkim was 39144, including 2 active cases and 38690 recoveries and 452 deaths. as of 18 april, the total number of cases was 39148, including 4 active cases and 38692 recoveries and 452 deaths. as of 1 may, the total number of cases was 39153, including 4 active cases and 38697 cures and 452 deaths. as of 12 may, the total number of cases was 39154, including 1 active case and 38701 cures and 452 deaths. as of 28 may, the total number of cases was 39165, including no active case and 38713 cures and 452 deaths. there hasn't been any covid death in the state of sikkim in more than 2 months. as of 9 june, the total number of cases was 39175, including 9 active cases and 38713 cures and 453 fatal cases. as of 16 june, the total number of cases was 39188, including 12 active cases and 38723 cures and 453 fatal cases. july to december 2022 as of 8 july, the total number of cases in sikkim was 39342, including 101 active cases and 38785 recoveries and 456 fatal cases. as of 26 august, the total number of cases was 43581, including 214 active cases and 42882 recoveries and 485 deaths. as of 31 august, the total number of cases was 43714, including 146 active cases and 43079 cures and 489 fatal cases. as of 10 september, the total number of cases was 43906, including 77 active cases and 43335 recoveries and 494 fatal cases. as of 24 september, the total number of cases was 44125, including 84 active cases and 43545 recoveries and 496 deaths. 2023 as of 22 march, the total number of cases in sikkim was 44333, including 4 active cases and 43829 recoveries and 500 fatal cases. testing summary of test results samples tested 110,183 positive 13,132 positive % 11.92% tests per million people 165,938 as of 23 may 2021 containment zones on 8 july 2020,state authorities declared 130 rcc, general reserve engineer force (gref) compound of rongli, east sikkim notified as containment zone after 6 new positive covid-19 cases. on 11 july 2020, rongli bazar, east sikkim have been declared containment zones due to the detection of 26 more positive covid-19 cases at 130 rcc, general reserve engineer force (gref) compound of nearby rongli bazar. on 15 july 2020,sikkim cm calls for enforcement of complete lockdown in rongli and pakyong subdivisions in east sikkim due to the recent spike in cases in these subdivisions. covid-19 vaccines with approval for emergency or conditional usage union minister for health & family welfare, dr. harsh vardhan visiting the gtb hospital, shahdara to review the preparedness of dry run of covid-19 vaccine, in delhi on january 02, 2021. main article: covid-19 vaccine covishield on january 1, 2021, the drug controller general of india, approved the emergency or conditional use of astrazeneca's covid-19 vaccine azd1222 (marketed as covishield). covishield is developed by the university of oxford and its spin-out company, vaccitech. it's a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. it can be stored, transported and handled at normal refrigerated conditions (two-eight degrees celsius/ 36-46 degrees fahrenheit). it has a shelf-life of at least six months. on 12 january 2021 first batches of covishield vaccine was despatched from the serum institute of india. covaxin on january 2, 2021, bbv152 (marketed as covaxin), first indigenous vaccine, developed by bharat biotech in association with the indian council of medical research and national institute of virology received approval from the drug controller general of india for its emergency or conditional usage. on 14 january 2021 first batches of covaxin vaccine was despatched from the bharat biotech, albeit it was still in the third phase of testing. others on 19 may 2021, dr reddy's labs received emergency use authorisation for anti-covid drug 2-dg. on 21 february, 2022, drugs controller general of india granted approval to biological e's covid-19 vaccine corbevax, that can be used for children between 12 and 18 years of age. on 21 october 2021, india completed administering of one billion covid vaccines in the country. on 8 january 2022, india crossed 1.5 billion covid vaccines milestone in the country. on 19 february 2022, india crossed 1.75 billion covid vaccines milestone in the country.